Pan-tuberculosis regimens: an argument for
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference9 articles.
1. Global tuberculosis report 2017,2017
2. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study;Sharma;Lancet Infect Dis,2017
3. Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB/RIF: a multisite observational study;Jacobson;Clin Infect Dis,2017
4. Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis;Cegielski;Clin Infect Dis,2014
5. Target regimen profiles for tuberculosis treatment,2016
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The potential distraction of a pan-regimen approach to tuberculosis;The Lancet Global Health;2024-08
2. Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis;PLOS Medicine;2024-05-03
3. One size does not fit all: community views on choices for TB treatment and prevention;Public Health Action;2023-09-21
4. Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis: a mathematical modeling analysis;2023-07-31
5. Are We Moving Towards Development of Universal Drug Regimen for Treatment of Tuberculosis?;The Indian Journal of Chest Diseases and Allied Sciences;2022-11-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3